VR headset could help schizophrenia patients kick the habit
NCT ID NCT07618338
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a 10-week virtual reality program could help people with schizophrenia stop smoking. 160 participants were split into a VR group or a no-treatment group. Researchers measured nicotine dependence, smoking behavior, and quality of life before and after the program. The goal was to see if immersive VR scenarios could support smoking cessation better than current methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Virtual reality-based smoking cessation program
What this could lead to
If it works, this could offer a new, engaging way to help people with schizophrenia quit smoking, improving their physical health and life expectancy.
What could go wrong
This is a small, completed study without a placebo control, so results may not be generalizable. The VR program may not work better than standard treatments, and long-term success is uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dokuz Eylul University Faculty of Medicine
Izmir, Balçova, 35330, Turkey (Türkiye)